These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26227663)

  • 1. The Role of Fludrocortisone in Cognition and Mood in Patients with Primary Adrenal Insufficiency (Addison's Disease).
    Schultebraucks K; Wingenfeld K; Otte C; Quinkler M
    Neuroendocrinology; 2016; 103(3-4):315-20. PubMed ID: 26227663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function in patients with primary adrenal insufficiency (Addison's disease).
    Schultebraucks K; Wingenfeld K; Heimes J; Quinkler M; Otte C
    Psychoneuroendocrinology; 2015 May; 55():1-7. PubMed ID: 25705797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
    Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E
    J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive deficits in patients with primary adrenal insufficiency.
    Tiemensma J; Andela CD; Biermasz NR; Romijn JA; Pereira AM
    Psychoneuroendocrinology; 2016 Jan; 63():170-7. PubMed ID: 26454105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals.
    Otte C; Wingenfeld K; Kuehl LK; Kaczmarczyk M; Richter S; Quante A; Regen F; Bajbouj M; Zimmermann-Viehoff F; Wiedemann K; Hinkelmann K
    Neuropsychopharmacology; 2015 Jan; 40(2):386-93. PubMed ID: 25035081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function in older adults with major depression: Effects of mineralocorticoid receptor stimulation.
    Otte C; Wingenfeld K; Kuehl LK; Richter S; Regen F; Piber D; Hinkelmann K
    J Psychiatr Res; 2015 Oct; 69():120-5. PubMed ID: 26343603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
    Campean R; Hasun M; Stöllberger C; Bucher J; Finsterer J; Schnack C; Weidinger F
    J Med Case Rep; 2016 Oct; 10(1):281. PubMed ID: 27729057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder.
    Wingenfeld K; Kuehl LK; Janke K; Hinkelmann K; Eckert FC; Roepke S; Otte C
    Neurobiol Learn Mem; 2015 Apr; 120():94-100. PubMed ID: 25732250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Addison's disease].
    Quinkler M
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):454-9. PubMed ID: 22907517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals.
    Hinkelmann K; Wingenfeld K; Kuehl LK; Fleischer J; Heuser I; Wiedemann K; Otte C
    Neurobiol Aging; 2015 Feb; 36(2):919-24. PubMed ID: 25442112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothyroidism and Addison's disease totally corrected by adrenal replacement therapy.
    Schwartz WL
    Calif Med; 1973 Feb; 118(2):57-60. PubMed ID: 4701710
    [No Abstract]   [Full Text] [Related]  

  • 13. Mineralocorticoid replacement in Addison's disease.
    Thompson DG; Mason AS; Goodwin FJ
    Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease.
    Tytherleigh MY; Vedhara K; Lightman SL
    Psychoneuroendocrinology; 2004 Jul; 29(6):712-23. PubMed ID: 15110920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of Addison's disease].
    Tiede N; Hofbauer LC; Bornstein SR; Kirch W
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1561-2. PubMed ID: 20665422
    [No Abstract]   [Full Text] [Related]  

  • 17. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging therapies for Addison's disease.
    Napier C; Pearce SH
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
    BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fatigue syndrome and Addison's disease.
    Baschetti R
    J Pediatr; 2003 Feb; 142(2):217; author reply 217-8. PubMed ID: 12584556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.